pHOXBIO Announces Breakthrough Clinical Trial Results Concluding Prophylactic Nasal Spray Prevents Infection from SARS-CoV-2
/PRNewswire/ -- pHOXBIO Ltd. today announced results from a randomized, double-blind, placebo-controlled clinical trial which demonstrate that pHOXWELL, its...
Source: prnewswire.com